REPUBLIC of MOLDOVA. Country experience. Title/Country. Presenter Title

Size: px
Start display at page:

Download "REPUBLIC of MOLDOVA. Country experience. Title/Country. Presenter Title"

Transcription

1 REPUBLIC of MOLDOVA. Country experience Title/Country Presenter Title 6 th GLI Partners Meeting ROMANCENCO ELENA 30 April 2 May 2014

2 REPUBLIC of MOLDOVA Independent from 1991 Ex-Soviet Union country, in continue transition period for ~ 20 years. Surface: 33.7 thousand sq. km. Population: 4,0 million. Migration: persons (to east and to west).

3 Despite multiple interventions in TB control in last period In TB treatment Universal access of treatment for I and II line. In TB diagnosis Implementation of a new, modern diagnostic tests (Xpert MTB/RIF, MGIT BACTEC, LPA). Universal access of all suspect new TB cases to these tests. In the medical community Training of GP. Financial assistance of GP by Medical Assurance Company for detection and treatment of TB patients. In general community Permanent, large information company for general population, risk groups. Support of TB patients (food, money, psychological support).

4 TB Incidence and Mortality, R. Moldova, Tb incidence - Rate/ TB Mortality - Rate/

5 MDR-TB among new and retreatment cases 70% 60% 50% 50% 51% 52% 59% 68% 65% 64% 62% 61% 40% 30% 20% 13% 19% 18% 24% 22% 25% 26% 24% 23% 10% 0% Ponderea MDR din caz nou, % Ponderea MDR din retratament

6 TB LABORATORY SERVICE IN MOLDOVA

7 TB Laboratory Service 1 NRL 3 RRL Micro; Xpert, LPA; LJ, MGIT (DST I, II line) 59 MC Micro; 16 of them has Xpert. Currier system work well for sputum transportation 7

8 Implementation of rapid methods for TB diagnostic and TB drug Resistance in Moldova MGIT ProbeTec MTBDRplus 2009 MTBDRsl MTBDRplus ver MODS PyroMark Xpert

9 EXPAND TB Project Came at the right time to consolidate and maintain laboratory activities for detection TB/MDR-TB/EXDR-TB cases. I Memorandum August 2010 First lot of reagents/consumables 2011 Support 3 RRL laboratories 80% of country. Funds around 1 mln $.

10 TB Laboratory Service Supported by EXPAND TB 1 NRL 2 RRL 10

11 MDR TB detection Planned to detect 1400 cases per each year Detected More than 2000 MDR-TB cases. 11

12 Additional contribution of EXPAND TB for laboratory TB service in Moldova

13 EXPAND TB PROJECT contribute (together with all our partners) to: Improve quality of TB diagnosis in country 1. Microbiological confirmation of TB was increased In %, in %. 2. Time for laboratory confirmation of TB was decreased Before weeks (LJ culture); after weeks. 3. Correct detection of TB according the susceptibility spectrum was improved. The time for initiation of correct treatment according DST results was decreased. Control infection measures was improved. due to increasing of the accessibility to rapid methods (MGIT, LPA) for all new suspect TB cases.

14 EXPAND TB PROJECT contribute to: Fortify laboratory capacity Implemented new methods in new RRL (LPA in Vorniceni); Procured new quality equipments (BACTEC, LPA equipments, BSC, autoclave, etc.); Procured new quality reagents, consumables; Flexible in planning - the plans were adjusted according the current situation and problem in country, strictly necessary at the moment. What else?

15 Together with EXPAND TB project we have become: - more professional, - more smart in Laboratory management - more prepare to face some problems

16 We learned how to forecast, to budget laboratory activities (EXPAND TB tool) Annual Budget Overview Area Reagents & consumables Costs (USD) total no. tests* costs / test** Microscopy 3, , Processing for culture 1, , Solid culture , Liquid culture 9, , DST liquid culture 3, LPA 24, , Xpert MTB/RIF 31, , Sub-Total 70, Biosafety & Cleaning Costs (USD) Biosafety 7, Cleaning 3, Sub-Total 10, * excluding repeats **including repeats

17 We learned how to prepare good specification of reagents, equipments on domestic acquisition (tender for MoH, GF, etc.) METHOD Family Sub Family ITEM NAME Supplier Specifications PROCESSING Instrument Laboratory, Miscellaneous Safety gas burner Gasprofi 1 SCS, saftey gas burnner, with foot switch, IR sensor, with rest heat display PROCESSING PROCESSING PROCESSING Instrument Instrument Instrument Laboratory, Miscellaneous Mixers, Shakers, Stirrers Mixers, Shakers, Stirrers PROCESSING Tools Centrifuges Safety gas tubing Overhead stirrer + Universal adapter Compact Orbital shaker (for BSC) Test tube rack 18/8 stainless steel 35 mn PROCESSING Tools Meters Alarm Clock Saftey gas tube 750mm long, with clamps inner diameter 9mm Overhead stirrer and universal adaptor, with individual ajustment from U/min, for 2 vessels, max weight 1 kg, universal adaptor for vessels from mm height Compact, universal small shaker suitable for shaking tasks with all small vessels and microtiter plates, ajustable speed of upto rpm Plates for 0.2ml PCR Tubes or Cryo vial 1.5ml or 2ml Test tube rack stainless steel, 3x7 places, 35mm Alarm clock, wiht stopfunction, digital, programmable for mx. 99 min, memory function, with alarm function at 0, 17

18 We learned how to check the functionality of BSC and other equipment (centrifuge, autoclave, etc.) 18

19 We learned how to monitor consumption and how to do inventory of stocks for consumables and reagents FIŞA Evidență Individuală Consumabile şi Reagenți Consumul lunar curent Sursa Unitate de măsură Cod Data expirării Alcool CNAM l Preț unitate Consumul lunar curent 40,07 MDL Lot T C de păstrare Mediu ultimele 3 l Maxim ultimele 3 l Minim ultimele 3 l PRIMIT DISTRIBUIT RĂMAS Nr. d/o Data Bon Cantitate Tehnician Data Cantitate Sector Tehnician Cantitate Tehnician /16/ ANS 8/22/ BACTEC VAC 2.75 ANS 3 8/22/ ANS 8/28/ PREP REAG CNV 9.75 ANS 4 8/28/ PREP TAMP MVI 8.35 ANS 5 9/2/ PCR GME 7.35 ANS 19

20 EXPAND TB PROJECT contribute to: Fortify staff capacity Laboratory staff (~25 persons) received training on working place on: Good Laboratory Practice; new implemented method (LPA for LRR Vorniceni); existing method (MGIT, LJ) as a refreshment for RRL, NRL; Interpretation of some doubt results (LPA).

21 Main challenges for project implementation

22 Some difficulties, NTP was not fully involved in the process. Custom clearance. Transportation from borders, custom to laboratories Installation of new equipment (autoclave, BSC, BACTEC) Include additional RRL (Bender for Transnistrian region) Training of physicians in correct requesting and understanding of new laboratory methods Store space, inventory of reagents, equipments. Solutions Project should be address through NTP, not directly to NRL. Solved by designate dedicated person, not from laboratories. Solved by contract transport company. Solved by local staff (autoclave, incubator); solved with external engineer for BACTEC; in process of solving for BSC. Not solved We address continue efforts in this direction In process. 22

23 But all something is start to finish. And now we should start to prepare for the new period

24 Due to support of EXPAND TB we start to develop Strategic Laboratory Plan To see the current situation and to plan real needs for future March 2014 I visit of FIND consultant Discussion of national policies in TB diagnosis Met with main partners and donors in TB control SWOT analysis with personal from NRL and RRL. April - first draft of the Strategic Laboratory Plan Next step Stakeholder meeting. Finalize plan and approve at national level.

25 To find FUTURE PARTNERS to support laboratory activities: And there are not many: Government, Ministry of Health, National Assurance Company: GF Microscopy ( ) I line drugs from ( ) and 100 patients for II line treatment (2014). Now we start planning for program. Address needs for more costly method Xpert, LPA, BACTEC. Research study. Clinical study.

26 Areas for future technical assistance of EXPAND TB or other partners To optimize TB diagnosis of patients through offer technical assistance to determine cost efficiency of new test, new algorithm (with less money to obtain better results); revising the current algorithm and improve/adapt to new conditions; offering the assistance for implementation of new methods in new territories (Xpert, sequencing method???, new methods); offering the consultancy in laboratory management (planning, budgeting of laboratories activities). To implement QMS in TB laboratories (MC, RRL, NRL) Train Responsible for QMS Train laboratory staff in basic QMS To help to achieve Accreditation in ISO for at least NRL in country.

27 Future plans, To finalize National Strategic Plan for TB Laboratory Service. To make a proposal for new GF project ( ). To start trainings in QMS for RRL. To find funds for accreditation of NRL in ISO To develop and implement an Integrated Laboratory Information System LIS (MGIT, Xpert, national system, laboratory local system) To participate in different operational, research project: In development of new methods (rapid, cheap, point of care test, new biomarkers). In development of new drugs. In implementation of new, individual more short scheme of treatment. But for all this activities we still need your support.

28 Thank you! We want to express our acknowledge for All EXPAND TB team, but Especially for Knut Fieldman, Maka Akalaia, Alexei Corobitin. 28

GDF Diagnostics. John Loeber Procurement Team Manager

GDF Diagnostics. John Loeber Procurement Team Manager GDF Diagnostics John Loeber Procurement Team Manager Joint UNICEF, UNFPA & WHO Meeting with Manufacturers and Suppliers Copenhagen, Denmark September 2013 1 GDF Diagnostics Overview 1. Standard Diagnostics

More information

Early Implementers of Xpert MTB/RIF: Jacob Creswell 18 April 2012

Early Implementers of Xpert MTB/RIF: Jacob Creswell 18 April 2012 Early Implementers of Xpert MTB/RIF: Experiences from TB REACH Jacob Creswell 18 April 2012 Overview Xpert MTB/RIF in TB REACH projects Case detection strategies Progress to date Innovations Challenges

More information

Recent Approaches in Detection of Drug- Resistant Tuberculosis. Dr M Hanif Bacteriologist Laboratory Division New Delhi Tuberculosis Centre

Recent Approaches in Detection of Drug- Resistant Tuberculosis. Dr M Hanif Bacteriologist Laboratory Division New Delhi Tuberculosis Centre Recent Approaches in Detection of Drug- Resistant Tuberculosis Dr M Hanif Bacteriologist Laboratory Division New Delhi Tuberculosis Centre Newer Diagnostic Methods for MDR TB Rapid Culture and DST using

More information

Assessing quality-assured diagnoses made by TB laboratories

Assessing quality-assured diagnoses made by TB laboratories Assessing quality-assured diagnoses made by TB laboratories Quality-assured TB laboratory Objectives: at the end of the assessment reviewers should comment on the laboratory network and its structure;

More information

Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrugresistant.

Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrugresistant. Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrugresistant tuberculosis Policy statement March 2010 1 Contents Abbreviations Executive summary 1.

More information

Positioning of TB Diagnostics within a Tiered System Integrated Approach from Reference to District Laboratory. Giorgio Roscigno CEO FIND

Positioning of TB Diagnostics within a Tiered System Integrated Approach from Reference to District Laboratory. Giorgio Roscigno CEO FIND Positioning of TB Diagnostics within a Tiered System Integrated Approach from Reference to District Laboratory Giorgio Roscigno CEO FIND Integrated Laboratory Network Definition An integrated laboratory

More information

A Practical Handbook for National TB Laboratory Strategic Plan Development

A Practical Handbook for National TB Laboratory Strategic Plan Development A Practical Handbook for National TB Laboratory Strategic Plan Development TB CARE A Practical Handbook for National TB Laboratory Strategic Plan Development Second English Edition February 2014 International

More information

Using new TB diagnostic tools: What is ( and is not) ready for prime time???

Using new TB diagnostic tools: What is ( and is not) ready for prime time??? Using new TB diagnostic tools: What is ( and is not) ready for prime time??? Eiman Mokaddas MD, FRCPath Professor of Clinical Microbiology Faculty of Medicine Kuwait University Footer Text 8/6/2015 1 Outline

More information

New Modalities in TB Diagnosis

New Modalities in TB Diagnosis New Modalities in TB Diagnosis The diagnosis in endemic countries depends more on the use of labour intensive, easy to use methodology with minimum infrastructure or equipment. The need is to find a viable

More information

Laboratory Strengthening through partnership. C.N.Paramasivan

Laboratory Strengthening through partnership. C.N.Paramasivan Laboratory Strengthening through partnership C.N.Paramasivan Background FIND was established s ed in 2003 To develop new affordable diagnostic test for TB To evaluate their efficacy To accelerate their

More information

Barriers on implementation of rapid methods of TB diagnosis

Barriers on implementation of rapid methods of TB diagnosis Barriers on implementation of rapid methods of TB diagnosis Turid Mannsåker National Reference Laboratory for Mycobacteria Norwegian Institute of Public Health TB in Norway around 1900: Among the highest

More information

ONSITE EVALUATION MECHANISM FOR CBNAAT LABORATORIES

ONSITE EVALUATION MECHANISM FOR CBNAAT LABORATORIES ONSITE EVALUATION MECHANISM FOR CBNAAT LABORATORIES S Anand, Hema Sundaram, Reena K, Mamatha H G, Anupurba Roy Chowdhury BACKGROUND With the advent of molecular tests for the detection of tuberculosis,

More information

Outcomes and follow-up of the GDF GeneXpert procurement stakeholders meeting, Paris, October 2013

Outcomes and follow-up of the GDF GeneXpert procurement stakeholders meeting, Paris, October 2013 Outcomes and follow-up of the GDF GeneXpert procurement stakeholders meeting, Paris, October 2013 Thomas Vergès GDF Country Support Officer EXPANDx-TB/Diagnostics What is the Global Drug Facility? An initiative

More information

Rapid molecular diagnosis of TB and drug-resistant TB

Rapid molecular diagnosis of TB and drug-resistant TB Rapid molecular diagnosis of TB and drug-resistant TB 2 nd European Advanced Course in Clinical Tuberculosis Amsterdam 2014 J. Domínguez Institut d Investigació Germans Trias i Pujol Universitat Autònoma

More information

Briefing: Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB. Karin Weyer 21 February 2011

Briefing: Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB. Karin Weyer 21 February 2011 Briefing: Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB Karin Weyer 21 February 2011 GeneXpert Xpert MTB/RIF 5 20 80 Samples per shift 500-1000 2 2 Multi-disease technology platform 3 >2010: CT/NG*;

More information

LABTRON. Orbital SHAKER LOS - SERIES.

LABTRON. Orbital SHAKER LOS - SERIES. LABTRON SHAKER LOS - SERIES www.labtron.com Email: info@labtron.com LOS-A Series: Our model of LOS-A Series is designed for shaking, mixing and aeration applications. It features adjustable speed control

More information

Monitoring and Evaluation Framework Specimen Referral Systems and Integrated Networks July 2018

Monitoring and Evaluation Framework Specimen Referral Systems and Integrated Networks July 2018 and Evaluation Framework Specimen Referral Systems and Integrated Networks July 2018 1 Table of Contents Overview of monitoring and evaluating specimen referral systems... 3 Theory of change... 3 M&E framework...

More information

Liquid culture Practical challenges with MGIT

Liquid culture Practical challenges with MGIT Reality check! Ensuring the pertinence of TB diagnostic tools for the peripheral l level Médecins Sans Frontières res Satellite IUATLD Conference,, Palais des Congrès, PARIS Sunday 19th October 2008 Liquid

More information

BENEFITS AND LIMITATIONS OF MOLECULAR TESTING

BENEFITS AND LIMITATIONS OF MOLECULAR TESTING BENEFITS AND LIMITATIONS OF MOLECULAR TESTING Test performance/ selection in various settings Edward Desmond, Ph.D., D (ABMM) California Dept. of Public Health Problem Pascopella, et al. 2004. Laboratory

More information

Introduction Background of the study

Introduction Background of the study 1 Introduction Tuberculosis (TB) is one of the leading cause of morbidity and mortality worldwide, affecting one-third of world population. Geographically, the incidence is much higher in Southeast Asia

More information

MOLECULAR LINE PROBE ASSAYS FOR RAPID SCREENING OF PATIENTS AT RISK OF MULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB) POLICY STATEMENT

MOLECULAR LINE PROBE ASSAYS FOR RAPID SCREENING OF PATIENTS AT RISK OF MULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB) POLICY STATEMENT MOLECULAR LINE PROBE ASSAYS FOR RAPID SCREENING OF PATIENTS AT RISK OF MULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB) POLICY STATEMENT 27 June 2008 POLICY STATEMENT MOLECULAR LINE PROBE ASSAYS FOR RAPID SCREENING

More information

Corning Life Science Equipment

Corning Life Science Equipment PROMOTIONAL OFFER Corning Life Science Equipment Liquid Handling Centrifugation Agitation Constant Temperature Valid May 1 st 2018 to December 15 th 2018 Promotion Liquid Handling Equipment Corning Stripettor

More information

Establishing Laboratory Facilities to Tackle the Challenge of MDR & XDR TB in the Kingdom of Lesotho

Establishing Laboratory Facilities to Tackle the Challenge of MDR & XDR TB in the Kingdom of Lesotho Establishing Laboratory Facilities to Tackle the Challenge of MDR & XDR TB in the Kingdom of Lesotho Dr. C.N. Paramasivan Foundation for Innovative New Diagnostics, Geneva Establishing NRL in Lesotho (1)

More information

Implementation of new diagnostic approaches and methods: operational considerations

Implementation of new diagnostic approaches and methods: operational considerations Implementation of new diagnostic approaches and methods: operational considerations Servicio Micobacterias Instituto Nacional de Enfermedades Infecciosas ANLIS Dr Carlos G. Malbran Argentina WHO/IUATLD

More information

Second Africa TB Regional Conference on Management of TB Medicines. Africa TB Conference 2012, Zanzibar December 5-7, 2012

Second Africa TB Regional Conference on Management of TB Medicines. Africa TB Conference 2012, Zanzibar December 5-7, 2012 Second Africa TB Regional Conference on Management of TB Medicines Africa TB Conference 2012, Zanzibar December 5-7, 2012 Country experience in planning, quantification and supply of MDR- TB medicines

More information

What is needed for Different Levels of TB Laboratory Accreditation

What is needed for Different Levels of TB Laboratory Accreditation What is needed for Different Levels of TB Laboratory Accreditation John C. Ridderhof, DrPH Laboratory Science, Policy and Practice Program Office/CDC WHO, Geneva 7 July 2011 The findings and conclusions

More information

Microplate. Shaker. Labtron Equipment Ltd

Microplate. Shaker. Labtron Equipment Ltd Microplate Shaker Labtron Equipment Ltd Basing View, Basingstoke, Hampshire RG21 4RG, UK Phone: +44 208 4329420 Email: info@labtron.com Webiste: www.labtron.com Email: info@labtron.com MICROPLATE SHAKER

More information

Mission-Report Laboratory expert mission from the SRL partner to Nepal 2017 Nepal June 2017

Mission-Report Laboratory expert mission from the SRL partner to Nepal 2017 Nepal June 2017 Mission-Report Laboratory expert mission from the SRL partner to Nepal 2017 Nepal June 2017 Supranational Reference Laboratory Munich-Gauting Kuratorium Tuberkulose in der Welt.V. Experts: Katja Haslauer

More information

Labs, Ledgers, and Lives Saved: The Impact of Diagnostic Strategies on the Epidemiology and Economics of Tuberculosis

Labs, Ledgers, and Lives Saved: The Impact of Diagnostic Strategies on the Epidemiology and Economics of Tuberculosis Labs, Ledgers, and Lives Saved: The Impact of Diagnostic Strategies on the Epidemiology and Economics of Tuberculosis David Dowdy, MD, PhD 9 th National Conference on Laboratory Aspects of Tuberculosis

More information

TB diagnostics: top 10 FAQs by test developers

TB diagnostics: top 10 FAQs by test developers 13 November 2012 Kuala Lumpur TB diagnostics: top 10 FAQs by test developers Madhukar Pai, MD, PhD Associate Professor McGill University, Montreal madhukar.pai@mcgill.ca The TB dx landscape in 2012 is

More information

Standard Operating Procedure (SOP) Specimen processing of CSF, lymph nodes and other tissues for Xpert MTB/RIF

Standard Operating Procedure (SOP) Specimen processing of CSF, lymph nodes and other tissues for Xpert MTB/RIF Page: 1 of 7 Content 1. Scope 2. Definitions and abbreviations 3. Procedure 3.1 Principle 3.2 General considerations 3.3 Specimen processing 3.3.1 Lymph nodes and other tissues (Xpert MTB/RIF only) 3.3.2

More information

GDF: Global mechanism to facilitate access to affordable quality assured TB medicines and diagnostics

GDF: Global mechanism to facilitate access to affordable quality assured TB medicines and diagnostics The Global Drug Facility (GDF) GDF: Global mechanism to facilitate access to affordable quality assured TB medicines and diagnostics Dr Kaspars Lunte Global Sourcing Officer, GDF 19 September 2017 Copenhagen

More information

Improving Access for Quality-Assured TB Medicines + Diagnostics Update on GDF Achievements & Strategic Framework Implementation

Improving Access for Quality-Assured TB Medicines + Diagnostics Update on GDF Achievements & Strategic Framework Implementation Improving Access for Quality-Assured TB Medicines + Diagnostics Update on GDF Achievements & Strategic Framework Implementation Andrea de Lucia Team Leader, Country Support 1 What is the Global Drug Facility?

More information

SIAPS assistance is grouped into four technical areas

SIAPS assistance is grouped into four technical areas Our specific approaches to each of the five result areas follows Governance Under SIAPS, our approach to improving governance and accountability focuses on establishing transparent management systems grounded

More information

त जप र व व / लय TEZPUR UNIVERSITY

त जप र व व / लय TEZPUR UNIVERSITY SHORT QUOTATION NOTICE TU/11-24/Pur/Qtn/2013/372-A dated 23/04/2013 Sealed quotations are invited for supply of the following items required for the research project of Dr. S.Saha, Department of MBBT,

More information

Update on GDF Model & Activities

Update on GDF Model & Activities Improving Access for Quality-Assured TB Medicines + Diagnostics Update on GDF Model & Activities Dr Joël Keravec GDF Manager Stop TB Partnership Forum Union Congress October 27 th, 2014 -Barcelona 1 Outline

More information

MICs in TB Susceptibility Testing: Challenges and Solutions for Implementation

MICs in TB Susceptibility Testing: Challenges and Solutions for Implementation MICs in TB Susceptibility Testing: Challenges and Solutions for Implementation Marie-Claire Rowlinson, PhD D(ABMM) Florida Bureau of Public Health Laboratories 8 th National Conference on Laboratory Aspects

More information

National and International Trends in Tuberculosis. Edward Desmond Microbial Diseases Laboratory California Dept. of Public Health

National and International Trends in Tuberculosis. Edward Desmond Microbial Diseases Laboratory California Dept. of Public Health National and International Trends in Tuberculosis Edward Desmond Microbial Diseases Laboratory California Dept. of Public Health Trend 1: The number of TB cases is decreasing In the USA (significantly),

More information

Global Drug Facility. An innovative approach to supplying anti-tb drugs

Global Drug Facility. An innovative approach to supplying anti-tb drugs Global Drug Facility An innovative approach to supplying anti-tb drugs Andrea de Lucia Team Leader, Regional Support and Capacity Building 2-3 April 2009 What is the GDF? An initiative of the Global Partnership

More information

INTRODUCTION. History RAYPA was founded by Mr. Ramón Espinar nd generation take over New makeover

INTRODUCTION. History RAYPA was founded by Mr. Ramón Espinar nd generation take over New makeover INTRODUCTION INTRODUCTION History 1970 RAYPA was founded by Mr. Ramón Espinar 2008 2 nd generation take over 2016 New makeover 2018 30 employees Turn over: 3.6 M 85% Sales on Export Sales in more than

More information

Incorporating New TB Diagnostics into RePORT

Incorporating New TB Diagnostics into RePORT Incorporating New TB Diagnostics into RePORT Susan Dorman Johns Hopkins University School of Medicine REPORT MEETING, DURBAN, JULY 2016 MACS designed to: 1. Elucidate the natural history of the infection

More information

DRAFT UGANDA STANDARD

DRAFT UGANDA STANDARD DRAFT UGANDA STANDARD DUS 1666 First Edition 2017-01-02 Polystyrene for its safe use in contact with foodstuffs, pharmaceuticals and drinking water Specification Reference number DUS 1666: 2017 UNBS 2017

More information

The New Diagnostics WG and The Global Plan to Stop TB

The New Diagnostics WG and The Global Plan to Stop TB The New Diagnostics WG and The Global Plan to Stop TB 2011-2015 Working Group on New Diagnostics Annual Meeting 11 th November 2010, Berlin Christian Lienhardt Stop TB Partnership Geneva Aims of this presentation

More information

Evaluation of Mycobacterium tuberculosis viability in OMNIgene-SPUTUM reagent upon multi-day transport at ambient temperature

Evaluation of Mycobacterium tuberculosis viability in OMNIgene-SPUTUM reagent upon multi-day transport at ambient temperature Tagliani et al. BMC Infectious Diseases (2017) 17:663 DOI 10.1186/s12879-017-2756-3 TECHNICAL ADVANCE Open Access Evaluation of Mycobacterium tuberculosis viability in OMNIgene-SPUTUM reagent upon multi-day

More information

ExpiCHO Expression System

ExpiCHO Expression System APPLICATION NOTE ExpiCHO Expression System ExpiCHO Expression System Protocols for 24 and 96 deep well blocks and mini bioreactor tubes The Gibco ExpiCHO Expression System brings together a high-expressing

More information

Improving Access for Quality-Assured TB Medicines + Diagnostics

Improving Access for Quality-Assured TB Medicines + Diagnostics Improving Access for Quality-Assured TB Medicines + Diagnostics Update on GDF New Strategic Direction: Achievements and Perspectives Joël Keravec GDF Special Adviser Stop TB Partnerships Workshop Union

More information

Public private partnerships

Public private partnerships THE INTERNATIONAL CONFERENCE ON (RE-)EMERGING INFECTIOUS DISEASES 14 March 2018 in Addis Ababa, Ethiopia Public private partnerships Engaging the private research sector to scale up infectious diseases

More information

Laboratory Facilities & Equipment List Sci-Tech Daresbury

Laboratory Facilities & Equipment List Sci-Tech Daresbury Laboratory Facilities & Equipment List Sci-Tech Daresbury Science and Technology Facilities Council provides specialist equipped laboratory facilities to give ambitious entrepreneurs, start-ups and SME

More information

Evaluation of the BD BACTEC MGIT 320 for Detection of Mycobacteria and. Drug Susceptibility testing of Mycobacterium tuberculosis

Evaluation of the BD BACTEC MGIT 320 for Detection of Mycobacteria and. Drug Susceptibility testing of Mycobacterium tuberculosis JCM Accepts, published online ahead of print on 17 July 2013 J. Clin. Microbiol. doi:10.1128/jcm.01357-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 Evaluation

More information

Pharmaceutical Management and Scaling up MDR-TB Care Delivery: Last mile Challenges and Solutions. Andre Zagorski November 12, 2012 Kuala Lumpur

Pharmaceutical Management and Scaling up MDR-TB Care Delivery: Last mile Challenges and Solutions. Andre Zagorski November 12, 2012 Kuala Lumpur Pharmaceutical Management and Scaling up MDR-TB Care Delivery: Last mile Challenges and Solutions Andre Zagorski November 12, 2012 Kuala Lumpur USAID-funded Systems for Improved Access to Pharmaceuticals

More information

WHO SRLs and Phenotypic Resistance

WHO SRLs and Phenotypic Resistance WHO SRLs and Phenotypic Resistance CPTR Rapid DST 2014 Workoshop Daniela M Cirillo, MD, PhD San Raffaele Scientific Institute Milan Outline SRLN EQAs Differences in data sets Delamanid testing: current

More information

Science Laboratory Technology

Science Laboratory Technology DACUM Skill Rating Scale 1 - Can perform some parts of this skill satisfactorily but requires assistance and/or supervision to perform the entire skill. 2 - Can perform this skill satisfactorily but requires

More information

Global Fund TB Project Coordinator

Global Fund TB Project Coordinator Global Fund TB Project Coordinator Location: [Africa] [Somalia] [Mogadishu] Category: Health Job Type: Fixed term, Full-time For Somali Nationals Only Purpose of the position: The position holder will

More information

Stool GeneXpert MTB/Rif Assay

Stool GeneXpert MTB/Rif Assay Stool GeneXpert MTB/Rif Assay Standard Operating Procedure 1.0. Purpose The purpose of this standard operating procedure (SOP) is to detail the steps for correctly performing, interpreting, and documenting

More information

Thermoshaker INCUBATOR

Thermoshaker INCUBATOR www.labtron.com LTSI-SERIES Thermoshaker INCUBATOR Email: info@labtron.com Thermo Shaker Incubator LTSI-A10 Our model of Thermo Shaker Incubator LTSI-A10 is compact, highly-efficient and consist several

More information

Supranational Reference Laboratory Network Business Plan. Possible approaches to a public health business plan April 2013

Supranational Reference Laboratory Network Business Plan. Possible approaches to a public health business plan April 2013 Supranational Reference Laboratory Network Business Plan Possible approaches to a public health business plan April 2013 SRLN Business Plan Outline Assumptions Environmental assessment, competitive advantage,

More information

Reference Standards for TB Microscopy Studies

Reference Standards for TB Microscopy Studies Reference Standards for TB Microscopy Studies Andrew Whitelaw Andrew.Whitelaw@uct.ac.za Why Microscopy? Diagnose active TB Quick Cheap Still first choice in many resource limited settings Will detect NTMs

More information

Guidelines on minimum recommendations for official laboratory appointed for the detection of Trichinella in meat

Guidelines on minimum recommendations for official laboratory appointed for the detection of Trichinella in meat Guidelines on minimum recommendations for official laboratory appointed for the detection of Trichinella in meat Introduction These guidelines provide a set of minimum recommendations to recognize the

More information

Dr Christopher Gilpin Laboratories, Diagnosticss and Drug Resistance Unit. Geneva, Switzerland. 4 th Annual GLI Meeting, th April 2012

Dr Christopher Gilpin Laboratories, Diagnosticss and Drug Resistance Unit. Geneva, Switzerland. 4 th Annual GLI Meeting, th April 2012 Current status of SRL Network Dr Christopher Gilpin Laboratories, Diagnosticss and Drug Resistance Unit WHO Stop TB Department Geneva, Switzerland 1 4 th Annual GLI Meeting, 17-19 th April 2012 Outline

More information

THE BEACON OPTOFLUIDIC PLATFORM. 1000s of cells 100X the insights 10X faster 1/X total cost BERKELEY LIGHTS. DIGITAL CELL BIOLOGY AT LIGHT SPEED.

THE BEACON OPTOFLUIDIC PLATFORM. 1000s of cells 100X the insights 10X faster 1/X total cost BERKELEY LIGHTS. DIGITAL CELL BIOLOGY AT LIGHT SPEED. THE BEACON OPTOFLUIDIC PLATFORM 1000s of cells 100X the insights 10X faster 1/X total cost BERKELEY LIGHTS. DIGITAL BIOLOGY AT LIGHT SPEED. FINDING THE MOST IMPORTANT INDIVIDUAL S REQUIRES THE MOST TIME,

More information

Model BF 720 Incubators Avantgarde.Line with forced convection

Model BF 720 Incubators Avantgarde.Line with forced convection Model BF 720 Incubators Avantgarde.Line with forced convection The BINDER incubator of the BF Avantgarde.Line series with forced convection is suitable for all gentle incubation applications, particularly

More information

Lab Soul, India.

Lab Soul, India. +91-8048719621 Lab Soul, India https://www.indiamart.com/labsoul-india/ We are emerging as one of the foremost manufacturer, exporter and suppliers of collection of Pharmaceutical Machines. Owing to its

More information

KBWF 240 (E5.1) - Plant growth chamber with optimal climatic conditions

KBWF 240 (E5.1) - Plant growth chamber with optimal climatic conditions Plant growth chambers KBWF 240 (E5.1) - Plant growth chamber with optimal climatic conditions The closest thing to natural conditions. Making use of the multifaceted programming options, we achieve perfect

More information

StopTB / GDF technical assistance mission in the DRC December 3-15 December 2018

StopTB / GDF technical assistance mission in the DRC December 3-15 December 2018 StopTB / GDF technical assistance mission in the DRC December 3-15 December 2018 DRC is one of the 30 priority countries in the world where the incidence of tuberculosis is high. PSM challenges are huge

More information

WELCOME TO THE FUTURE OF TRANSIENT EXPRESSION. Smart start guide for the ExpiCHO system

WELCOME TO THE FUTURE OF TRANSIENT EXPRESSION. Smart start guide for the ExpiCHO system WELCOME TO THE FUTURE OF TRANSIENT EXPRESSION Smart start guide for the ExpiCHO system 2 Contents Smart start tips 6 Shake grid 7 Frequently asked questions (FAQs) Getting started 8 Cell handling 8 Medium

More information

Validation of 2 nd line drug susceptibility testing. Ed Desmond California Dept. of Public Health

Validation of 2 nd line drug susceptibility testing. Ed Desmond California Dept. of Public Health Validation of 2 nd line drug susceptibility testing Ed Desmond California Dept. of Public Health XDRTB!!! KwaZulu-Natal outbreak, 2006 53 HIV-infected patients, 52 deaths Average survival from specimen

More information

NovaWAVE. A new category of Automated Microwave Digestion

NovaWAVE. A new category of Automated Microwave Digestion A new category of Automated Microwave Digestion NovaWAVE US Patent Number 8,454,910 B2 AGRICULTURE GEOLOGY ENVIRONMENT Textiles Increase Throughput - Digest up to 168 samples Mixed samples in the same

More information

Request for Applications: PHL Reference Center for Mycobacterium tuberculosis complex Drug Susceptibility Testing

Request for Applications: PHL Reference Center for Mycobacterium tuberculosis complex Drug Susceptibility Testing Request for Applications: PHL Reference Center for Mycobacterium tuberculosis complex Drug Susceptibility Testing Application Due Date: October 13, 2014 Submit to: Kelly Wroblewski, Director of Infectious

More information

RECIPROCAL SHAKER.

RECIPROCAL SHAKER. RECIPROCAL SHAKER www.labocon.com Note: The color of the actual product may differ from the color pictured in this catalog due to printing limitation. Reciprocal Shaker LRS-100 Series Labocon Reciprocal

More information

Clarifications to tender EuropeAid/134252/C/SUP/ME - Supply of equipment to the Blood Transfusion Institute

Clarifications to tender EuropeAid/134252/C/SUP/ME - Supply of equipment to the Blood Transfusion Institute EUROPEAN UNION DELEGATION TO MONTENEGRO Operations Section Clarifications to tender EuropeAid/134252/C/SUP/ME - Supply of equipment to the Blood Transfusion Institute Reference to Technical Specifications

More information

Model BF 260 Incubators Avantgarde.Line with forced convection

Model BF 260 Incubators Avantgarde.Line with forced convection Model BF 260 Incubators Avantgarde.Line with forced convection The BINDER incubator of the BF Avantgarde.Line series with forced convection is suitable for all gentle incubation applications, particularly

More information

+91-8048763605 Krishna Scientific Suppliers http://www.krishnascientificsuppliers.com/ We, Krishna scientific suppliers, are reliable firm involved in manufacturing & exporting of Industrial Fermenter,

More information

12. Environmental-, soil-, water-, food analysis Sample preparation for standard methods

12. Environmental-, soil-, water-, food analysis Sample preparation for standard methods GENERAL CATALOGUE EDITION 7. Environmental-, soil-, water-, food analysis Sample preparation for standard methods behrotest waste water mixers With portable sample vessel. Homogenizer for pre-treatment,

More information

Model BF 56 Standard-Incubators with forced convection

Model BF 56 Standard-Incubators with forced convection Model BF 56 Standard-Incubators with forced convection The BINDER incubator of the BF Avantgarde.Line series with forced convection is suitable for all gentle incubation applications, particularly under

More information

Mixer Mill MM 400. General Information. Application Examples. Product Advantages. Features. Product Information

Mixer Mill MM 400. General Information. Application Examples. Product Advantages. Features. Product Information General Information The mixer mill MM 400 is a compact versatile bench-top unit, which has been developed specially for dry, wet and cryogenic grinding of small amounts of sample. It can mix and homogenize

More information

dependable sample protection Trusted reliability Worldwide support Environmental stability Innovative design

dependable sample protection Trusted reliability Worldwide support Environmental stability Innovative design Thermo Scientific Cytomat Series Automated Incubators and Storage Systems dependable sample protection Trusted reliability Worldwide support Environmental stability Innovative design Thermo Scientific

More information

Maunank Shah 1*, Violet Chihota 2, Gerrit Coetzee 3, Gavin Churchyard 2,4,5 and Susan E Dorman 1

Maunank Shah 1*, Violet Chihota 2, Gerrit Coetzee 3, Gavin Churchyard 2,4,5 and Susan E Dorman 1 Shah et al. BMC Infectious Diseases 2013, 13:352 RESEARCH ARTICLE Open Access Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant

More information

DIGIBLOCK SOLUTIONS IN SAMPLE PREPARATION

DIGIBLOCK SOLUTIONS IN SAMPLE PREPARATION DIGIBLOCK SOLUTIONS IN SAMPLE PREPARATION WWW.LABTECHSRL.COM THE BEST CHOICE FOR SAMPLE DIGESTION The DigiBlock digestion system provides clean, economical and efficient digestions. The DigiBlock heating

More information

Nano Series. Gene Series. Table Top Series. Delivering Innovative Laboratory Supply for Advanced Scientific Discoveries.

Nano Series. Gene Series. Table Top Series. Delivering Innovative Laboratory Supply for Advanced Scientific Discoveries. Nano Series Gene Series Table Top Series Delivering Innovative Laboratory Supply for Advanced Scientific Discoveries www.hercuvan.com Volume 4 Company Incorporated in 2011, Hercuvan Lab Systems is a company

More information

Model KB 720 Cooling incubators with compressor technology

Model KB 720 Cooling incubators with compressor technology Model KB 720 Cooling incubators with compressor technology The powerful virtuoso in cooling incubators for microorganisms: the KB masters temperature ranges from -5 C to 100 C. The new KB series consumes

More information

Laboratory Management Training

Laboratory Management Training Laboratory Management Training A Means of Supporting Future Leaders of Public Health Laboratories equilabration 2008 Annual Meeting May 18-21, 2008 St. Louis, MO Session Overview Review the development

More information

HHMI SEA PHAGES Project Project Information and Associate Application. Submission Deadline: November 15, 2014

HHMI SEA PHAGES Project Project Information and Associate Application. Submission Deadline: November 15, 2014 HHMI SEA PHAGES Project 2015-2016 Project Information and Associate Application Submission Deadline: November 15, 2014 The HHMI Science Education Alliance-Phage Hunters Advancing Genomics and Evolutionary

More information

Fighting Drug Resistance in Russia: Challenges and Achievements. Wieslaw Jakubowiak, M.D. WHO TB Control Programme in the Russian Federation

Fighting Drug Resistance in Russia: Challenges and Achievements. Wieslaw Jakubowiak, M.D. WHO TB Control Programme in the Russian Federation Fighting Drug Resistance in Russia: Challenges and Achievements Wieslaw Jakubowiak, M.D. WHO TB Control Programme in the Russian Federation IOM Drug Forum Workshop: November 5, 2008 TB notification and

More information

Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis

Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis 454 Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 111(7): 454-459, July 2016 Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis drugs

More information

9th National Conference on the Laboratory Aspects of Tuberculosis

9th National Conference on the Laboratory Aspects of Tuberculosis 9th National Conference on the Laboratory Aspects of Tuberculosis Expected discrepancies between molecular and growth-based DST: Which technology is giving the right answer? Edward Desmond, CA Dept. of

More information

POLICY IMPLEMENTATION PACKAGE FOR NEW TB DRUG INTRODUCTION. Summary

POLICY IMPLEMENTATION PACKAGE FOR NEW TB DRUG INTRODUCTION. Summary POLICY IMPLEMENTATION PACKAGE FOR NEW TB DRUG INTRODUCTION Summary The landscape of drug development for treatment of tuberculosis (TB) has evolved dramatically over the past 10 years. Newly developed

More information

Quantum Perfusion Systems

Quantum Perfusion Systems Quantum Perfusion Systems Quantum Perfusion Systems Spectrum Medical proudly presents an exciting new generation of Extracorporeal Technologies and Integrated Patient Safety Systems designed specifically

More information

CS Automated haemostasis testing. Medium workload high class.

CS Automated haemostasis testing. Medium workload high class. CS-1600 Automated haemostasis testing. Medium workload high class. www.sysmex-europe.com Challenges in haemostasis testing In haemostasis, test results can point out major clinical issues, some of which

More information

SI-02. Features. Electromagnetic Flowmeter for General Applications. Description: Application:

SI-02. Features. Electromagnetic Flowmeter for General Applications. Description: Application: SI-02 Electromagnetic Flowmeter for General Applications Description: Features / Universally applicable / Separate or compact measuring transmitter / Variety of lining material / DN15 to DN2000 / DIN-

More information

CUJ/ P&S/ CAC/ UGC Project/001/2013; Dated:

CUJ/ P&S/ CAC/ UGC Project/001/2013; Dated: झ रखण ड क न द र य व श व द य लय, र च CENTRAL UNIVERSITY OF JHARKHAND, RANCHI (स सद य अध न यम क तहत 2009 म स थ व त क न द र य व श व द य लय) (A Central University established by an Act of Parliament in 2009)

More information

Rapid Diagnosis of Tuberculosis

Rapid Diagnosis of Tuberculosis Rapid Diagnosis of Tuberculosis Ed DESMOND Richmond, US I. Rapid Diagnosis Methods I would like to discuss rapid diagnosis methods of tuberculosis. The traditional method is acid fast microscopy. However,

More information

Laboratory Methods: Tuberculosis Diagnosis

Laboratory Methods: Tuberculosis Diagnosis Laboratory Methods: Tuberculosis Diagnosis Grace Lin Research Scientist MDL, CA Dept of Public Health Grace.lin@cdph.ca.gov Curry International TB Center 10-19-17 Topics Diagnostic testing Smear and Culture

More information

RIDA Anreicherungsbouillon

RIDA Anreicherungsbouillon RIDA Anreicherungsbouillon mtsb for the enrichment of shigatoxin-producing E. coli bacteria Article no: Z1000 Article no: Z1003 R-Biopharm AG, An der neuen Bergstraße 17, D-64297 Darmstadt, Germany Tel.:

More information

XpertMTB/RIF Implementation through USAID-supported

XpertMTB/RIF Implementation through USAID-supported XpertMTB/RIF Implementation through USAID-supported Programs Amy Piatek USAID/Washington April 8, 2011 USAID is currently working in 40 countries Category Focus Countries (20) Other Countries (20) Countries

More information

Partnership. Large Steam Autoclaves for the Life Sciences. Laboratory Line

Partnership. Large Steam Autoclaves for the Life Sciences. Laboratory Line Partnership Large Steam Autoclaves for the Life Sciences Laboratory Line Large Steam Autoclaves for the Life Sciences Sterilization in a laboratory environment has its unique requirements. Tuttnauer laboratory

More information

Model KB 23 Cooling incubators with compressor technology

Model KB 23 Cooling incubators with compressor technology Model KB 23 Cooling incubators with compressor technology The most versatile among the cooled incubators for microorganisms: The BINDER KB series cooled incubator controls temperature ranges of -5 C to

More information

Improving Availability and Reducing the Price of MDR-TB Drugs. Inder Singh, EVP, Access Programs Clinton Health Access Initiative (CHAI)

Improving Availability and Reducing the Price of MDR-TB Drugs. Inder Singh, EVP, Access Programs Clinton Health Access Initiative (CHAI) Improving Availability and Reducing the Price of MDR-TB Drugs Inder Singh, EVP, Access Programs Clinton Health Access Initiative (CHAI) 1 Context: The availability and high price of second-line drugs (SLDs)

More information

DRIVE YOUR DATA FORWARD AUTOMATIC PASSENGER COUNTING SOLUTIONS. For Transit Buses

DRIVE YOUR DATA FORWARD AUTOMATIC PASSENGER COUNTING SOLUTIONS. For Transit Buses DRIVE YOUR DATA FORWARD AUTOMATIC PASSENGER COUNTING SOLUTIONS For Transit Buses Ideal for : Bus Manufacturers, Integrators & Bus Fleet Operators and Transit Agencies Automatic Passenger Counting For Transit

More information

Dynamiker Biotechnology (Tianjin) Co., Ltd. Dynamiker Aspergillus Galactomannan Assay. Catalogue No.: DNK User Manual / 96 tests

Dynamiker Biotechnology (Tianjin) Co., Ltd. Dynamiker Aspergillus Galactomannan Assay. Catalogue No.: DNK User Manual / 96 tests Dynamiker Biotechnology (Tianjin) Co., Ltd. DNK-SM-1402-1 A/0 Dynamiker Aspergillus Galactomannan Assay Catalogue No.: DNK-1402-1 User Manual / 96 tests CONTENTS 1. INTENDED USE... 1 2. PRINCIPLE... 1

More information

TB Lab Methods and Their Limitations

TB Lab Methods and Their Limitations TB Lab Methods and Their Limitations Alla Ostash Supervisor of TB, STD and Central Accessioning Units WA Public Health Laboratory June 2018 Objectives Upon completion of this training, participants will

More information